News & insights

Next-generation TB vaccines, expected to become available from 2029, could deliver major health and economic gains, helping to save an estimated 7.3 million lives, generate up to US$ 135 billion in economic benefits for low-and middle-income…

WHO prequalification of a multi-dose RSV maternal vaccine marks a major step towards protecting newborns and infants from one of the leading causes of severe respiratory illness, hospitalisation and death worldwide.

Cervical cancer remains one of the leading causes of cancer-related deaths for women in Papua New Guinea, with over 1,000 women diagnosed and ~650 deaths annually.